Oncology Medical Device Technologies Market Scope
Oncology devices are medical equipment that are used to diagnose, manage, and treat cancer. Oncology devices are classified into two types: brachytherapy devices and endoscopic devices. Endoscopic devices are medical equipment that are used to diagnose, manage, and treat cancer. It is used to peer inside a bodily cavity or organ. These are employed in a variety of therapies, including chemotherapy, hormone therapy, biotherapy/immunotherapy, and radiation therapy, and are utilized by a variety of end-users, including hospitals and cancer research institutions. Endoscopic devices are medical equipment that are used to diagnose, manage, and treat cancer. CRISPR, artificial intelligence, telemedicine, the Infinium Assay, cryo-electron microscopy, and robotic surgery are all helping to expedite cancer research.
Attributes | Details |
---|
Study Period | 2018-2028 |
Base Year | 2022 |
Unit | Value (USD Million) |
Key Companies Profiled | AIROS Medical Inc., GE Healthcare, Eckert & Ziegler BEBIG, Oncura Inc., GE Healthcare, Medtronic PLC., Varian Medical Systems Inc., Elekta AB, Theragenics Corporation, Accuray Incorporated, Roche Diagnostics and IBA Group |
CAGR | % |
The competitive landscape of the market includes information by competitor. Company overview, financials, revenue generated, market potential, investment in R&D, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance are all included. The data points presented above are only linked to the companies concentration on the medical device technology market. Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global Oncology Medical Device Technologies market throughout the predicted period.
AIROS Medical Inc., GE Healthcare, Eckert & Ziegler BEBIG, Oncura Inc., GE Healthcare, Medtronic PLC., Varian Medical Systems Inc., Elekta AB, Theragenics Corporation, Accuray Incorporated, Roche Diagnostics and IBA Group are some of the key players that are part of study coverage.
About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from the total available market.
Segmentation Overview
The study have segmented the market of Global Oncology Medical Device Technologies market by Type and Region with country level break-up.
On the basis of geography, the market of Oncology Medical Device Technologies has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).
region held largest market share in the year 2022.
Market Leaders and their expansionary development strategies
In May 2021, GE Healthcare acquired Zionexa for an undisclosed amount. The acquisition would help GE healthcare to develop more personalized treatments for cancer. Zionexa is a French developer of cancer and neurology biomarkers.
Influencing Trend:
Growing awareness about healthcare and The expansion of the medical device technologies
Market Growth Drivers:
A growing number of cancer cases and Increase in Consumption of Tobacco Products
Challenges:
Data security concerns may impede growth prospects
Restraints:
The low per capita expenditure on healthcare in developing countries and High cost of oncology devices
Opportunities:
The increasing incidence of cancer is contributing to the surge in demand for oncology devices to treat cancer patients
Key Target Audience
Pharmaceuticals Manufacturers, Medical Technology Association of India, FDA Medical Device Industry, Advanced Medical Technology Association, Medical Device Manufacturers Association and Others